Did targeted therapy fail cyclooxygenase too?
- PMID: 17050864
- DOI: 10.1200/JCO.2006.08.0622
Did targeted therapy fail cyclooxygenase too?
Comment on
-
Randomized phase II trial of docetaxel/irinotecan and gemcitabine/irinotecan with or without celecoxib in the second-line treatment of non-small-cell lung cancer.J Clin Oncol. 2006 Oct 20;24(30):4825-32. doi: 10.1200/JCO.2006.07.4773. J Clin Oncol. 2006. PMID: 17050867 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical